Classification and molecular biology of polycythemias (erythrocytoses) and thrombocytosis.
In this article, polycythemic disorders are classified based on the current understanding of biology of erythropoieses and divided into primary and secondary polycythemias. Special emphasis is given to recently uncovered molecular bases of newly described congenital polycythemic disorders. This clarification of the pathophysiology of some of the congenital polycythemic states has obvious utility for more accurate diagnosis and rational prognostic determination. The molecular basis of congenital thrombocytoses is only beginning to be uncovered. In contrast, the molecular bases of polycythemia vera and essential thrombocythemia remain unknown, thus their diagnostic criteria are imprecise and their treatment remains largely empirical. The central premise of this article is that deciphering the molecular basis of human diseases leads to improved understanding of hematopoiesis, precise diagnosis, and the potential for development of a specific therapy.
Prchal
Josef T
JT
Section of Hematology/Oncology, Baylor College of Medicine, One Baylor Plaza, MS 525D, Houston, TX 77030, USA. jprchal@bcm.tmc.edu
D006801:Humans; D007674:Kidney Diseases / Q000235:genetics; D008107:Liver Diseases / Q000235:genetics; D009154:Mutation; D011086:Polycythemia / Q000145:classification* / Q000235:genetics*; D013922:Thrombocytosis / Q000145:classification* / Q000235:genetics*